Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 70.79M | 84.95M | 101.93M | 116.67M | 119.30M |
Total Other Revenue | 277.64M | 325.96M | 408.74M | 441.01M | 455.93M |
Total Revenue | 348.43M | 410.91M | 510.67M | 557.68M | 575.23M |
Cost of Revenue | 321.46M | 350.14M | 380.47M | 397.24M | 404.04M |
Gross Profit | 26.98M | 60.77M | 130.20M | 160.44M | 171.18M |
SG&A Expenses | 182.27M | 156.71M | 133.52M | 118.77M | 100.98M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -18.10M | 12.28M | 1.05M | 4.17M | 4.28M |
Total Operating Expenses | 493.48M | 526.99M | 522.90M | 524.90M | 513.44M |
Operating Income | -145.05M | -116.08M | -12.23M | 32.78M | 61.79M |
Income Before Tax | -1.08B | -944.15M | -1.31B | -1.24B | -830.24M |
Income Tax Expenses | 872.00K | 858.00K | 859.00K | 820.00K | 800.00K |
Earnings from Continuing Operations | -1.08K | -945.00 | -1.32K | -1.25K | -831.04 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -1.08B | -945.00M | -1.32B | -1.25B | -831.04M |
EBIT | -145.05M | -116.08M | -12.23M | 32.78M | 61.79M |
EBITDA | -51.83M | -12.14M | 100.98M | 151.15M | 175.70M |
EPS Basic | -1.99 | -6.46 | -5.37 | -5.28 | -4.21 |
Normalized Basic EPS | -2.20 | -3.19 | -4.07 | -3.65 | -2.70 |
EPS Diluted | -1.99 | -6.46 | -5.51 | -5.42 | -4.36 |
Normalized Diluted EPS | -2.20 | -3.19 | -4.12 | -3.70 | -2.75 |
Average Basic Shares Outstanding | 1.23B | 1.09B | 1.01B | 1.09B | 1.18B |
Average Diluted Shares Outstanding | 1.23B | 1.09B | 1.06B | 1.14B | 1.23B |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |